Bonesupport Holding AB operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Bonesupport Holding AB with three other
pharmaceutical manufacturers in Europe:
sales of 6.80 million Euro [US$7.98 million]
(7.46 million Euro [US$8.75 million]
of which 72%
was Research & Development Tax Credit), and
Biomed Lublin Wytwornia Surowic I Szczepionek SA
based in Poland
(31.40 million Polish New Zlotys [US$8.57 million]
of which 94%
was Plasma Segment).